A Phase 1b/2 Trial of AMG 386 in Combination with Pemetrexed and Carboplatin as First Line Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer
|Effective start/end date||6/1/13 → 3/31/14|
- AMGEN INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.